1. Home
  2. JBL vs NTRA Comparison

JBL vs NTRA Comparison

Compare JBL & NTRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • JBL
  • NTRA
  • Stock Information
  • Founded
  • JBL 1966
  • NTRA 2003
  • Country
  • JBL United States
  • NTRA United States
  • Employees
  • JBL N/A
  • NTRA N/A
  • Industry
  • JBL Electrical Products
  • NTRA Medical Specialities
  • Sector
  • JBL Technology
  • NTRA Health Care
  • Exchange
  • JBL Nasdaq
  • NTRA Nasdaq
  • Market Cap
  • JBL 21.7B
  • NTRA 24.9B
  • IPO Year
  • JBL 1993
  • NTRA 2015
  • Fundamental
  • Price
  • JBL $203.04
  • NTRA $168.81
  • Analyst Decision
  • JBL Strong Buy
  • NTRA Strong Buy
  • Analyst Count
  • JBL 9
  • NTRA 17
  • Target Price
  • JBL $228.78
  • NTRA $192.41
  • AVG Volume (30 Days)
  • JBL 1.7M
  • NTRA 1.1M
  • Earning Date
  • JBL 09-25-2025
  • NTRA 11-11-2025
  • Dividend Yield
  • JBL 0.16%
  • NTRA N/A
  • EPS Growth
  • JBL N/A
  • NTRA N/A
  • EPS
  • JBL 5.92
  • NTRA N/A
  • Revenue
  • JBL $29,802,000,000.00
  • NTRA $1,964,250,000.00
  • Revenue This Year
  • JBL $4.33
  • NTRA $24.28
  • Revenue Next Year
  • JBL $6.54
  • NTRA $15.22
  • P/E Ratio
  • JBL $34.23
  • NTRA N/A
  • Revenue Growth
  • JBL 3.18
  • NTRA 44.38
  • 52 Week Low
  • JBL $108.66
  • NTRA $117.27
  • 52 Week High
  • JBL $237.14
  • NTRA $183.00
  • Technical
  • Relative Strength Index (RSI)
  • JBL 40.09
  • NTRA 55.73
  • Support Level
  • JBL $201.65
  • NTRA $157.43
  • Resistance Level
  • JBL $219.00
  • NTRA $164.88
  • Average True Range (ATR)
  • JBL 7.63
  • NTRA 5.38
  • MACD
  • JBL -2.26
  • NTRA -0.66
  • Stochastic Oscillator
  • JBL 9.15
  • NTRA 50.42

About JBL Jabil Inc.

Jabil Inc is a United States-based company engaged in providing manufacturing services and solutions. It provides comprehensive electronics design, production and product management services to companies in various industries and end markets.The Company derives its revenue from providing comprehensive electronics design, production and product management services. It operates in two segments. The Electronics Manufacturing Services (EMS) segment, which is the key revenue driver, is focused on leveraging IT, supply chain design and engineering, technologies largely centered on core electronics. The Diversified Manufacturing Services (DMS) segment is focused on providing engineering solutions, with an emphasis on material sciences, technologies, and healthcare.

About NTRA Natera Inc.

Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.

Share on Social Networks: